CN Patent

CN101365423B — 缓释小分子药物制剂

Assigned to Alza Corp · Expires 2012-11-21 · 13y expired

What this patent protects

本发明涉及缓释小分子药物制剂。本发明提供了一种可注射的长效制剂，所述制剂包含生物相容性聚合物、与所述生物相容性聚合物结合以形成粘性凝胶的有机溶剂以及掺入所述粘性凝胶中的小分子药物，从而使得所述制剂显示出C max 与C mix 之比小于200且滞后时间小于0.2的体内释放曲线。

USPTO Abstract

本发明涉及缓释小分子药物制剂。本发明提供了一种可注射的长效制剂，所述制剂包含生物相容性聚合物、与所述生物相容性聚合物结合以形成粘性凝胶的有机溶剂以及掺入所述粘性凝胶中的小分子药物，从而使得所述制剂显示出C max 与C mix 之比小于200且滞后时间小于0.2的体内释放曲线。

Drugs covered by this patent

Patent Metadata

Patent number
CN101365423B
Jurisdiction
CN
Classification
—
Expires
2012-11-21
Drug substance claim
No
Drug product claim
No
Assignee
Alza Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.